1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Take to The Barricades!

Discussion in 'Alkermes' started by anonymous, Jan 16, 2020 at 1:22 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Wow...the revolution is on! Check out the posting under "Seriously, am I the only one who thinks...".

    To quote Little Richard; "A Whole Lotta Shakin' Goin' On"!

  2. anonymous

    anonymous Guest

    Finally! A call to action. Deeds not words!
  3. anonymous

    anonymous Guest

    Emailing “info@insertcompanyname” is going to change something? Sounds about as effective as the initiatives around activity tracking that Keck and Nichols have been been throwing down.